Belladonna alkaloids, tertiary amines
Atropine Sulfate
The FDA lists this product in 32 strengths and forms.
Indications
Atropine Sulfate Ophthalmic Solution, USP 1% is indicated for: Atropine is an anti-muscarinic agent indicated for: Mydriasis ( 1.1 ) Cycloplegia ( 1.2 ) Penalization of the healthy eye in the treatment of amblyopia ( 1.3 )
1.1 Mydriasis
1.2 Cycloplegia
1.3 Penalization of the Healthy Eye in the Treatment of Amblyopia
Contraindications
Atropine Sulfate Ophthalmic Solution, USP 1% should not be used in anyone who has demonstrated a previous hypersensitivity or known allergic reaction to any ingredient of the formulation because it may recur. Hypersensitivity or allergic reaction to any ingredient in the formulation ( 4 ).
Warnings and precautions
Photophobia and blurred vision due to pupil unresponsiveness and cycloplegia may last up to 2 weeks ( 5.1 ). Risk of blood pressure increase from systemic absorption ( 5.2 ). To avoid the potential for eye injury or contamination, care should be taken to avoid touching the single-dose vial to the eye or to any other surface ( 5.3 ).
5.1Photophobia and Blurred Vision Photophobia
and blurred vision due to pupil unresponsiveness and cycloplegia may last up to 2 weeks.
5.2Elevation of Blood Pressure Elevation
in blood pressure from systemic absorption has been reported following conjunctival instillation of recommended doses of Atropine Sulfate Ophthalmic Solution, USP 1%.



